Skip to content
drillr.ai
Sign up

BRVE

Braveheart Bio, Inc.

NASDAQ · Healthcare · Biotechnology · US

$26.74
+1.79%
Ask drillr
13
Insider buys (3m)
0
Insider sells (3m)
$159.0M
Net value (3m)
—
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 11, 2026AH Bio Fund IV, L.P. · 10 percent ownerPurchase1,100,000$18
Aug 11, 2026Chimovits Erez · director, 10 percent owner: Purchase1,666,667$18
Aug 11, 2026Chimovits Erez · director, 10 percent owner: Purchase273,333$18
Aug 11, 2026ORBIMED ADVISORS LLC · director, 10 percent owner: Purchase1,666,667$18
Aug 11, 2026ORBIMED ADVISORS LLC · director, 10 percent owner: Purchase273,333$18
Aug 7, 2026Chimovits Erez · director, 10 percent owner: A-Award30,000$18
Aug 7, 2026Viehbacher Christopher · directorPurchase83,333$18
Aug 7, 2026Viehbacher Christopher · directorA-Award30,000$18
Aug 7, 2026Malek David I · directorPurchase4,166$18
Aug 7, 2026Malek David I · directorA-Award30,000$18
Aug 7, 2026Anderson Michele A. · officer: Chief Development OfficerPurchase1,111$18
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A. · 10 percent ownerPurchase1,920,000$18
Aug 7, 2026Murdoch Travis · director, officer: CEO and PresidentPurchase83,333$18
Aug 7, 2026Murdoch Travis · director, officer: CEO and PresidentA-Award550,000$20
Aug 7, 2026Bos Jasper · directorA-Award30,000$18
Aug 7, 2026Lubner David Charles · directorPurchase55,555$18
Aug 7, 2026Lubner David Charles · directorA-Award60,000$18
Aug 7, 2026Anderson Michele A. · officer: Chief Development OfficerA-Award300,000$18
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A. · 10 percent ownerPurchase1,680,000$18
Aug 7, 2026Rickey James Paul · officer: Chief Financial OfficerPurchase27,777$18
Aug 7, 2026Rickey James Paul · officer: Chief Financial OfficerA-Award300,000$18
Aug 7, 2026Lohoff Tim · directorA-Award30,000$18

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 11, 2026